Table 3.
Distribution of patients according to demographic and clinicopathological characteristics
| Study variable | Number of patients (N) | Percentages (%) |
|---|---|---|
| Age (in years) |
|
|
| ≤45 |
97 |
68.3 |
| >45 |
45 |
31.7 |
| Sex |
|
|
| Male |
98 |
69.0 |
| Female |
44 |
31.0 |
| Duration of symptoms (in weeks) |
|
|
| ≤16 |
17 |
12.0 |
| >16 |
125 |
88.0 |
| HBsAg |
|
|
| Positive |
94 |
66.2 |
| Negative |
48 |
33.8 |
| HCV antibody |
|
|
| Positive |
24 |
16.9 |
| Negative |
118 |
83.1 |
| HIV status |
|
|
| Positive |
13 |
9.2 |
| Negative |
129 |
90.8 |
| HCC type |
|
|
| Multiple discrete lesions |
70 |
49.3 |
| Diffuse lesions |
52 |
26.6 |
| Solitary lesions |
20 |
14.1 |
| Solitary lesions |
|
|
| >10 cm |
12 |
60.0 |
| 5-10 cm |
5 |
25.0 |
| <5 cm |
3 |
15.0 |
| Okuda stage |
|
|
| I |
- |
- |
| II |
34 |
23.2 |
| III |
108 |
76.8 |
| Child-Pugh class |
|
|
| A |
- |
- |
| B |
39 |
27.5 |
| C |
103 |
72.5 |
| Histopathological grade |
|
|
| Well differentiated |
84 |
59.2 |
| Moderately differentiated |
18 |
12.7 |
| Poorly differentiated | 40 | 28.1 |